Stock listing

NASDAQ:APLS Apellis Pharmaceuticals, Inc. Stock

Home listing (NASDAQ) of Apellis Pharmaceuticals, Inc.

Follow Apellis Pharmaceuticals, Inc. into a list and get an email when it puts out news.

Apellis Pharmaceuticals, Inc. logo
Ticker
NASDAQ:APLS
Asset type
Stock
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Replays

  • Apellis Pharmaceuticals (NASDAQ:APLS) Q4 2025 Earnings Call

    Tue, Feb 24, 2026 · 8:30 AM ET

    Watch Transcript

  • Apellis Pharmaceuticals (NASDAQ:APLS) Q3 2025 Earnings Call

    Thu, Oct 30, 2025 · 8:30 AM ET

    Watch Transcript

  • Apellis Pharmaceuticals (NASDAQ:APLS) Q2 2025 Earnings Call

    Thu, Jul 31, 2025 · 8:30 AM ET

    Watch Transcript

Latest news

Canada’s Drug Agency Issues Positive Reimbursement Recommendation for EMPAVELI® (pegcetacoplan) for the Treatment of C3G and Primary IC-MPGN

Jul 9, 2026

Biogen to Acquire Apellis, Enhancing the Company’s Growth Portfolio in Immunology and Rare Disease, Bolstering Growth Outlook and Accelerating Expansion into Nephrology

Mar 31, 2026

Apellis Announces Mikael Dolsten, M.D., Ph.D., to Join Board of Directors

Mar 2, 2026

Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results

Feb 24, 2026

Apellis Pharmaceuticals to Present at the TD Cowen 46th Annual Health Care Conference

Feb 23, 2026

Apellis Announces Eight Oral Presentations at the 49th Macula Society Annual Meeting

Feb 19, 2026

Apellis Pharmaceuticals to Host Conference Call on February 24, 2026, to Discuss Fourth Quarter and Full Year 2025 Financial Results

Feb 10, 2026

Apellis Highlights Commercial Execution and Strategic Priorities at the 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026

Apellis Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference

Jan 5, 2026

Sobi Receives Positive CHMP Opinion for Aspaveli® (pegcetacoplan) for the Treatment of C3G and Primary IC-MPGN

Dec 12, 2025

All Apellis Pharmaceuticals, Inc. news

Decks

Apellis Pharmaceuticals, Inc. on 6ix

News releases
16 in the last 12 months · 191 in all · newest Jul 9, 2026 · oldest 2019
Calls
20 calls with a replay · 20 with a transcript · latest Feb 24, 2026
Decks
12 decks · latest Feb 24, 2026

Where Apellis Pharmaceuticals, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:APLS · Home listing · This pageNASDAQUnited StatesUSD
gettex:1JKgettexGermanyEUR
Tradegate:1JKTradegateGermanyEUR
BOATS:APLSBOATSUnited StatesUSD
LS Exchange:A2JAAWLS ExchangeGermanyEUR
Lang & Schwarz:A2JAAWLang & SchwarzGermanyEUR
BX Swiss:APLSBX SwissSwitzerlandCHF
Milan:1APLSMilanItalyEUR
Frankfurt:1JKFrankfurtGermanyEUR
Dusseldorf:1JKDusseldorfGermanyEUR
Munich:1JKMunichGermanyEUR
Stuttgart:1JKStuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Apellis Pharmaceuticals, Inc.